Cargando…
Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEGG. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139265/ https://www.ncbi.nlm.nih.gov/pubmed/34154837 http://dx.doi.org/10.1016/j.regg.2021.05.002 |
| _version_ | 1783695972313858048 |
|---|---|
| author | López Castro, José |
| author_facet | López Castro, José |
| author_sort | López Castro, José |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8139265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SEGG. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81392652021-05-24 Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? López Castro, José Rev Esp Geriatr Gerontol Letter to the Editor SEGG. Published by Elsevier España, S.L.U. 2021 2021-05-21 /pmc/articles/PMC8139265/ /pubmed/34154837 http://dx.doi.org/10.1016/j.regg.2021.05.002 Text en © 2021 SEGG. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor López Castro, José Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title | Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title_full | Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title_fullStr | Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title_full_unstemmed | Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title_short | Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care? |
| title_sort | approach to post-covid-19 syndrome (pc19s): how long to maintain corticotherapy and heparin after discharge from intensive care? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139265/ https://www.ncbi.nlm.nih.gov/pubmed/34154837 http://dx.doi.org/10.1016/j.regg.2021.05.002 |
| work_keys_str_mv | AT lopezcastrojose approachtopostcovid19syndromepc19showlongtomaintaincorticotherapyandheparinafterdischargefromintensivecare |